Telematics tech biz Microlise says an attack that hit its network likely did not expose customer data, although staff aren’t so lucky.
“Some limited employee data” was compromised in the incident, Microlise told the London Stock Exhchange today, without going into any great detail about the…
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
